Abstract Title: currently loading...

information currently loading...

Loading ... please wait
timer Loading ... please wait

Free Paper Session 11: New Drug Treatment Session

Date/Time: | Room:

Back to Previous



16:30:00 F. Patelli Italy Evaluation of a portable artificial vision device among patients affected by retinitis pigmentosa implanted with Argus II retina prosthesis
16:36:00 J. Zarranz-Ventura Spain Assessing the effectiveness of fluocinolone acetonide (0.2 micrograms/day FAc) and dexamethasone (DEX 700 micrograms) steroid implants in DME phase III pivotal trials using the areaunderthecurve (AUC) method: The constant analysis
16:42:00 J. Christoforidis United States Systemic biodistribution and intravitreal pharmacokinetic properties of bevacizumab, ranibizumab and aflibercept in a nonhuman primate model
16:48:00 Y. Solberg Switzerland Fluorescence lifetime imaging ophthalmoscopy: Quantitative analysis in macular telangiectasia type 2
16:54:00 S. Mamtora United Kingdom Smart Phone Ophthalmoscopy a potential replacement for the direct ophthalmoscope
17:00:00 R. Shah India Use of biosimiliar ranibuzumab( razumab) in macular pathology
17:06:00 J. Olea Vallejo Spain Silicone oil microdroplets contamination source for intravitreal injections
17:12:00 B. Schworm Germany Subtreshold Laser Treatment in chronic central serous chorioretinopathy: a prospective interventional study
17:18:00 M. Porcu Belgium Antiinflammatory effects of the PIGF neutralizing antibody THR317 in patients with diabetic macular edema
17:24:00 B. LeRoy Belgium Year 3 results and agestratified analyses for a phase 3 trial of voretigene neparvovec in RPE65 mutation–associated inherited retinal disease
17:30:00 M. Fischer Germany Improved retinal sensitivity in a Phase 2 choroideremia gene therapy trial
17:36:00 M. Patricio United Kingdom Biocompatibility and stability of a viral vector used in retinal gene therapy
17:42:00 Y. Le Mer France Subretinal implantations of PRIMA wireless photovoltaic chip, a new surgical technique for atrophic dry agerelated macular degeneration: Technical feasibility and early results
17:48:00 A. Sharma India Intraocular pressure (IOP) after intravitreal dexamethasone implant (ozurdex) In different geographic populations in real world GEODEXIOP study

Want to find out more about EURETINA activities?

Contact us
© EURETINA All rights reserved